- Veracyte to Present at 10th Annual SVB Leerink Global Healthcare Conference
- Veracyte Announces Fourth Quarter and Full-Year 2020 Financial Results
- Veracyte to Present at BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
- Veracyte to Release Fourth Quarter and Full-Year 2020 Financial Results on February 17, 2021
- Veracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
- Veracyte Announces Pricing of Upsized Public Offering of 7,432,433 Shares of Common Stock
- Veracyte Announces Proposed Public Offering of Common Stock
- Veracyte to Acquire Decipher Biosciences
- Veracyte Announces Preliminary Fourth Quarter and Full-Year 2020 Financial Results
- Veracyte to Participate in 23rd Annual Needham Virtual Growth Conference
More ▼
Key statistics
On Friday, Veracyte Inc (VCYT:NMQ) closed at 58.06, -32.51% below its 52-week high of 86.03, set on Feb 10, 2021.
52-week range
Markit short selling activity
Open | 59.35 |
---|---|
High | 61.87 |
Low | 55.50 |
Bid | 55.00 |
Offer | 79.33 |
Previous close | 58.06 |
Average volume | 1.04m |
---|---|
Shares outstanding | 67.00m |
Free float | 64.72m |
P/E (TTM) | -- |
Market cap | 3.89bn USD |
EPS (TTM) | -0.6686 USD |
Data delayed at least 15 minutes, as of Feb 26 2021 21:00 GMT.
More ▼